METHYL 4-BROMO-5-METHOXY-2-NITROBENZOATE, 95.0%, 1g

4-(((4'-methoxy-[1,1'-biphenyl])-4-sulfonamido)methyl)benzoic acid, 95.0%, 1g

2,6-Dimethylpiperidine, 95.0%, 1g

4-[(E)-4-Pyridinylazo]pyridine, 97%, 25g

3-(4-(TRIFLUOROMETHYL)PHENYL)CYCLOBUTANONE, 95.0%, 1g

4,4'-Oxybis(methylbenzene), 95.0%, 5g

(R)-Methyl 2-(4-hydroxyphenoxy)propanoate, 95.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)(methyl)amino)hexanoic acid, 98%, 5g

GC-Kapillarsäule ROTI®Cap-5, 50 m, 0.25 mm, 0.10 µm, unpolar, 1 Stück

1,6-Hexanediaminium, N1,N6-bis[3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]-N1,N1,N6,N6-tetramethyl-, bromide (1:2), 98%, 100mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 95.0%, 5g

1,6-Di(pyridin-3-yl)hexane, 1g

MES, 500 g